The federal contract IDV award described is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Department of Veterans Affairs to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $627,800,000 and an ultimate completion date of April 30, 2025.
Under this FSS contract, Fresenius Kabi USA, LLC has been awarded multiple delivery orders by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services. These orders, valued at over $10 million in total, are for the procurement and replenishment of pharmaceutical products such as sodium chloride injection bags and meropenem injection vials for the Strategic National Stockpile, a federal repository of critical medical supplies for emergency preparedness and response. Additionally, Fresenius Kabi USA, LLC has received a delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 12 for the supply of the antibiotic gentamicin. All of these delivery orders are issued under firm fixed-price terms against the Pharmaceuticals and Drugs FSS contract, which does not carry any set-aside designations.
Generated 3/13/25, 9:59 AM